Sign in

CIK 0001453687

  • Non-accelerated filer
  • Smaller reporting company

Cartesian Therapeutics, Inc.

Sign in to watch
Ticker
RNAC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 301-348-8698
Business address
7495 NEW HORIZON WAY, FREDERICK, MD, 21703
Former names
SELECTA BIOSCIENCES INC
  1. 4 Open-market sale President and CEO sold 2,692 shares at $1.66 ($4,470)
  2. 4 Open-market sale President and CEO sold 4,768 shares at $1.85 ($8,810)
  3. 4 Open-market buy Director bought 130,000 shares at $1.15 ($149,799)
  4. 4 Option exercise President and CEO acquired 10,938 shares (option exercise)
  5. 4 Open-market buy Director bought 50,000 shares at $0.77 ($38,720)
  6. 4 Open-market buy Director bought 6,681,600 shares
  7. 4 Open-market sale President and CEO sold 5,443 shares at $1.81 ($9,863)
  8. 4 Option exercise Director acquired 10,000 shares (option exercise)
  9. 4 Open-market sale Chief Medical Officer sold 3,226 shares at $3.09 ($9,955)
  10. 4 Open-market sale Chief Scientific Officer sold 3,416 shares at $3.09 ($10,541)
  11. 4 Open-market sale Chief Operations Officer sold 3,416 shares at $3.09 ($10,541)
  12. 4 Open-market sale President and CEO sold 13,597 shares at $3.09 ($41,959)
  13. 4 Derivatives Options or other derivatives
  14. 4 Grant or award Chief Medical Officer acquired 90,200 shares (grant or award)
  15. 4 Grant or award Chief Financial Officer acquired 72,000 shares (grant or award)
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Grant or award Chief Scientific Officer acquired 72,000 shares (grant or award)
  20. 4 Grant or award Chief Operations Officer acquired 72,000 shares (grant or award)

Page 8 of 21 · 410 filings